ITRM20000106A0 - Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10. - Google Patents

Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10.

Info

Publication number
ITRM20000106A0
ITRM20000106A0 IT2000RM000106A ITRM20000106A ITRM20000106A0 IT RM20000106 A0 ITRM20000106 A0 IT RM20000106A0 IT 2000RM000106 A IT2000RM000106 A IT 2000RM000106A IT RM20000106 A ITRM20000106 A IT RM20000106A IT RM20000106 A0 ITRM20000106 A0 IT RM20000106A0
Authority
IT
Italy
Prior art keywords
propionil
carnitine
coenzyme
prevention
treatment
Prior art date
Application number
IT2000RM000106A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of ITRM20000106A0 publication Critical patent/ITRM20000106A0/it
Priority to IT2000RM000106A priority Critical patent/IT1316997B1/it
Priority to AU2001241030A priority patent/AU2001241030B8/en
Priority to MXPA02008532A priority patent/MXPA02008532A/es
Priority to AT01912113T priority patent/ATE335473T1/de
Priority to DK01912113T priority patent/DK1263423T3/da
Priority to PCT/IT2001/000081 priority patent/WO2001064203A2/en
Priority to PT01912113T priority patent/PT1263423E/pt
Priority to CA2400959A priority patent/CA2400959C/en
Priority to PL358178A priority patent/PL207536B1/pl
Priority to AU4103001A priority patent/AU4103001A/xx
Priority to ES01912113T priority patent/ES2269355T3/es
Priority to US10/220,186 priority patent/US6814972B2/en
Priority to HU0204467A priority patent/HU229421B1/hu
Priority to DE60122114T priority patent/DE60122114T2/de
Priority to SK1240-2002A priority patent/SK12402002A3/sk
Priority to EP01912113A priority patent/EP1263423B1/en
Priority to CZ20022758A priority patent/CZ20022758A3/cs
Priority to ARP010100861A priority patent/AR027958A1/es
Priority to TNTNSN01033A priority patent/TNSN01033A1/fr
Publication of ITRM20000106A1 publication Critical patent/ITRM20000106A1/it
Application granted granted Critical
Publication of IT1316997B1 publication Critical patent/IT1316997B1/it
Priority to CY20061101373T priority patent/CY1106168T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT2000RM000106A 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10. IT1316997B1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT2000RM000106A IT1316997B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
ES01912113T ES2269355T3 (es) 2000-03-02 2001-02-20 Composicion para la prevencion y/o tratamiento de enfermedades vasculares, constituida por l-carnitina de propionil y coencima q10.
HU0204467A HU229421B1 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
AT01912113T ATE335473T1 (de) 2000-03-02 2001-02-20 Zusammensetzung zur verhinderung und/oder behandlung von gefässerkrankungen, bestehend aus propionyl-l-carnitin und coenzym q10
DK01912113T DK1263423T3 (da) 2000-03-02 2001-02-20 Præparat til forebyggelse og/eller behandling af vaskulære sygdomme bestående af propionyl-L-carnitin og coenzym Q10
PCT/IT2001/000081 WO2001064203A2 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q¿10?
PT01912113T PT1263423E (pt) 2000-03-02 2001-02-20 Composição destinada à prevenção e/ou tratamento de doenças vasculares consistindo de propionil-l-carnitina e coenzima q10
CA2400959A CA2400959C (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
PL358178A PL207536B1 (pl) 2000-03-02 2001-02-20 Kompozycja do zapobiegania i/lub leczenia chorób naczyniowych oraz jej zastosowanie
AU4103001A AU4103001A (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q<sub>10</sub>
AU2001241030A AU2001241030B8 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10
US10/220,186 US6814972B2 (en) 2000-03-02 2001-02-20 Composition for prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10
MXPA02008532A MXPA02008532A (es) 2000-03-02 2001-02-20 Composicion para la prevencion y/o tratamiento de padecimientos vasculares, que comprende propionil l-carnitina y la coenzima q10.
DE60122114T DE60122114T2 (de) 2000-03-02 2001-02-20 Zusammensetzung zur verhinderung und/oder behandlung von gefässerkrankungen, bestehend aus propionyl-l-carnitin und coenzym q10
SK1240-2002A SK12402002A3 (sk) 2000-03-02 2001-02-20 Kompozícia pre prevenciu a/alebo liečenie cievnych ochorení obsahujúca propionyl L-karnitín a koenzým Q10
EP01912113A EP1263423B1 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, consisting of propionyl l-carnitine and coenzyme q10
CZ20022758A CZ20022758A3 (cs) 2000-03-02 2001-02-20 Přípravek k prevenci a/nebo léčbě vaskulárních onemocnění obsahující propionyl-L-karnitin a koenzym Q10
ARP010100861A AR027958A1 (es) 2000-03-02 2001-02-26 Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10
TNTNSN01033A TNSN01033A1 (fr) 2000-03-02 2001-02-27 Une composition pour la prevention et/ou le traitement des maladies vasculaires comportant le propionyl l- carnitine et la coenzyme q10.
CY20061101373T CY1106168T1 (el) 2000-03-02 2006-09-25 Συνθεση για την προληψη και/ή θepαπεια αγγειακων ασθενειων που συνισταται απο προπιονυλ l-καρνιτινη και συνενζυμο q10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000106A IT1316997B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.

Publications (3)

Publication Number Publication Date
ITRM20000106A0 true ITRM20000106A0 (it) 2000-03-02
ITRM20000106A1 ITRM20000106A1 (it) 2001-09-02
IT1316997B1 IT1316997B1 (it) 2003-05-26

Family

ID=11454491

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000106A IT1316997B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.

Country Status (19)

Country Link
US (1) US6814972B2 (it)
EP (1) EP1263423B1 (it)
AR (1) AR027958A1 (it)
AT (1) ATE335473T1 (it)
AU (2) AU4103001A (it)
CA (1) CA2400959C (it)
CY (1) CY1106168T1 (it)
CZ (1) CZ20022758A3 (it)
DE (1) DE60122114T2 (it)
DK (1) DK1263423T3 (it)
ES (1) ES2269355T3 (it)
HU (1) HU229421B1 (it)
IT (1) IT1316997B1 (it)
MX (1) MXPA02008532A (it)
PL (1) PL207536B1 (it)
PT (1) PT1263423E (it)
SK (1) SK12402002A3 (it)
TN (1) TNSN01033A1 (it)
WO (1) WO2001064203A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002309038B2 (en) * 2001-05-10 2007-05-17 Kaneka Corporation Compositions for transmucosal administration containing coenzyme Q as the active ingredient
TW200304373A (en) * 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Percutaneous absorption promoters and compositions for treating athlete's foot
WO2010127297A1 (en) 2009-05-01 2010-11-04 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
EP2582368B1 (en) * 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6232346B1 (en) * 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
ES2201467T3 (es) 1997-03-27 2004-03-16 Michael J. Sole Composicion nutritiva para la mejora energetica de la celula.
IT1299197B1 (it) * 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
IT1317008B1 (it) 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.

Also Published As

Publication number Publication date
CZ20022758A3 (cs) 2003-02-12
HUP0204467A2 (hu) 2003-06-28
EP1263423B1 (en) 2006-08-09
HUP0204467A3 (en) 2006-07-28
PL207536B1 (pl) 2010-12-31
AU4103001A (en) 2001-09-12
ITRM20000106A1 (it) 2001-09-02
US6814972B2 (en) 2004-11-09
SK12402002A3 (sk) 2003-02-04
HU229421B1 (en) 2013-12-30
DE60122114D1 (de) 2006-09-21
ATE335473T1 (de) 2006-09-15
WO2001064203A2 (en) 2001-09-07
AR027958A1 (es) 2003-04-16
TNSN01033A1 (fr) 2005-11-10
WO2001064203A3 (en) 2002-03-28
CY1106168T1 (el) 2011-06-08
CA2400959C (en) 2011-01-04
PL358178A1 (en) 2004-08-09
AU2001241030B8 (en) 2005-10-20
AU2001241030B2 (en) 2005-09-15
DE60122114T2 (de) 2007-02-08
IT1316997B1 (it) 2003-05-26
EP1263423A2 (en) 2002-12-11
PT1263423E (pt) 2006-11-30
ES2269355T3 (es) 2007-04-01
CA2400959A1 (en) 2001-09-07
DK1263423T3 (da) 2006-12-11
MXPA02008532A (es) 2003-02-12
US20030059418A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
BRPI0307673A2 (pt) métodos de tratar doença vascular.
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
WO2004006858A3 (en) Compounds, compositions, and methods employing same
MXPA01012184A (es) Composicion dietetica o farmaceutica para utilizarse en la prevencion o tratamiento de la hiperoxaluria.
DE60236367D1 (de) Echolöscher, der eine weitere reduktion des restechos sicherstellt
DK1066056T3 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, ...
ATE303386T1 (de) Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens
MXPA03006776A (es) Uso de inhibidores de interleucina-18 para el tratamiento y/o prevencion de enfermedad cardiaca.
ITRM20000106A0 (it) Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10.
MXPA03003032A (es) Terapia de combinacion para el tratamiento de una enfermedad sensible a los estrogenos.
ITMI20010262U1 (it) Mensola per elementi di arredo e simili.
IT1318420B1 (it) Stent perfezionato per la dilatazione di vasi sanguigni.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
IT244757Y1 (it) Piedino regimentato di costruzione semplificata , per scaffalaturemetalliche o per altri impieghi.
IT1306143B1 (it) Composizione per la prevenzione ed il trattamento delle alterazionimentali e comportamentali.
ZA200308844B (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
ITBO990406A0 (it) Profilato per la realizzazione di telai , particolarmente di letti e t avoli .
ITRM990762A0 (it) Procedimento per la preparazione di filati ondee o compensina.
ITMI20022263A1 (it) Composizioni per il trattamento delle emorroidi.
ES1048757Y (es) Calzado perfeccionado.
AU2001241974A1 (en) Actinomycin d for the treatment of vascular disease
ITPN20020071A1 (it) Procedimento per la fabbricazione di mobili.
ITRM20010329A1 (it) Catetere indolore.
IT249899Y1 (it) Espositore perfezionato di gioielli, particolarmente per vetrine.